Serge Lyashchenko, PharmD

About Me

I am a registered radiopharmacist specializing in the development of immunoPET and theranostics agents. I have been practicing radiopharmacy more than ten years.

My work focuses on safely using radiation to treat various diseases. I supervise the manufacturing of novel molecular imaging agents in MSK’s state-of-the-art Radiochemistry and Molecular Imaging Probe Core Facility. Additionally, I am actively involved in early agent development strategies with both academic and industry colleagues. These plans will ensure that new agents can move beyond first-in-human studies and possibly become the standard care in the future.

I am a member of the Investigation New Drug Committee, Radiology Quality Assurance Committee, Committee on Radiation, and Radioactive Drug Research Committee. With these groups, I ensure efficient and controlled development of molecular imaging agents, with the overarching goal of providing the best cancer care.

Working at MSK is especially rewarding because it involves collaboration with a broad range of multidisciplinary teams. I very much enjoy working with preclinical development teams because I can continuously generate new ideas.

  • Clinical Expertise: Radiopharmacy
  • Languages Spoken: English; Russian; Ukrainian
  • Education: PharmD, Ernest Mario School of Pharmacy, Rutgers University


Visit PubMed for a full listing of Serge Lyashchenko’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.